Faculty

Back to Index
Matthew Kirkpatrick, PhD
Assistant Professor of Research Preventive Medicine
Preventive Medicine
SSB 2001 N Soto St Health Sciences Campus Los Angeles
+1 323 442 8221

Overview

Matt Kirkpatrick, PhD is an Assistant Professor of Research in the Department of Preventive Medicine in the Keck School of Medicine at the University of Southern California. He is associate director of the USC-Health, Emotion, & Addiction Laboratory (USC-HEAL), which conducts interdisciplinary research at the intersection between drug abuse, emotion, and health-related behaviors. He earned his B.A. in Religious Studies at the University of North Carolina at Chapel Hill and Ph.D. in Psychology at Columbia University. Dr. Kirkpatrick completed postdoctoral training in neuropsychopharmacology at the University of Chicago.

Publications

Anhedonia and Abstinence as Predictors of the Subjective Pleasantness of Positive, Negative, and Smoking-Related Pictures. Nicotine Tob Res. 2017 Feb 10. View in: PubMed

Electronic cigarette retailers use Pokémon Go to market products. Tob Control. 2017 Jan 02. View in: PubMed

Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 Dec; 11(6):592-9. View in: PubMed

Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration. Psychoneuroendocrinology. 2016 Dec; 74:92-100. View in: PubMed

Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology. Drug Alcohol Depend. 2016 Nov 1; 168:176-180. View in: PubMed

Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology (Berl). 2016 Oct 22. View in: PubMed

Transdiagnostic processes linking anxiety symptoms and substance use problems among adolescents. J Addict Dis. 2016 Jul 18; 1-12. View in: PubMed

Premenstrual symptoms and smoking-related expectancies. Addict Behav. 2016 Jun; 57:38-41. View in: PubMed

Social Self-Control Is a Statistically Nonredundant Correlate of Adolescent Substance Use. Subst Use Misuse. 2016 May 11; 51(6):788-94. View in: PubMed

Social contexts of momentary craving to smoke among Korean American emerging adults. Addict Behav. 2016 May; 56:23-9. View in: PubMed

Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures. Pharmacol Biochem Behav. 2016 May; 144:73-7. View in: PubMed

Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium. Behav Genet. 2016 Mar; 46(2):170-82. View in: PubMed

Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016 Feb; 73:71-8. View in: PubMed

Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl). 2016 Jan; 233(1):89-97. View in: PubMed

Diminished Alternative Reinforcement as a Mechanism Underlying Socioeconomic Disparities in Adolescent Substance Use. Prev Med. 2015 Nov; 80:75-81. View in: PubMed

Initial Validation of the Pleasure and Health Behavior Inventory - A Measure of Motivation to Engage in Health-damaging Behavior to Overcome Deficient Pleasure. Am J Health Behav. 2015 Sep; 39(5):652-64. View in: PubMed

Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study. Hum Psychopharmacol. 2015 Sep; 30(5):364-71. View in: PubMed

Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015 Aug 18; 314(7):700-7. View in: PubMed

Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. JAMA Psychiatry. 2015 Jul 1; 72(7):642-50. View in: PubMed

Prosocial effects of MDMA: A measure of generosity. J Psychopharmacol. 2015 Jun; 29(6):661-8. View in: PubMed

Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12. View in: PubMed

Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77. View in: PubMed

Examination of anxiety sensitivity and distress tolerance as transdiagnostic mechanisms linking multiple anxiety pathologies to alcohol use problems in adolescents. Alcohol Clin Exp Res. 2015 Mar; 39(3):532-9. View in: PubMed

MDMA: a social drug in a social context. Psychopharmacology (Berl). 2015 Mar; 232(6):1155-63. View in: PubMed

MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905. View in: PubMed

'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81. View in: PubMed

Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology. 2014 Aug; 46:23-31. View in: PubMed

Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63. View in: PubMed

In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl). 2013 Nov; 230(2):215-26. View in: PubMed

Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine. J Addict Med. 2013 May-Jun; 7(3):163-8. View in: PubMed

Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64. View in: PubMed

Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction. 2012 Apr; 107(4):783-91. View in: PubMed

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):109-22. View in: PubMed

Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):191-204. View in: PubMed

Zolpidem does not serve as reinforcer in humans subjected to simulated shift work. Drug Alcohol Depend. 2010 Nov 1; 112(1-2):168-71. View in: PubMed

Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes. Psychopharmacology (Berl). 2009 May; 203(4):771-80. View in: PubMed

Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology. 2008 Jul; 33(8):1847-55. View in: PubMed

Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008 Apr 1; 94(1-3):258-62. View in: PubMed

Effects of intranasal methamphetamine on metacognition of agency. Psychopharmacology (Berl). 2008 Mar; 197(1):137-44. View in: PubMed

Powered bySC CTSI